BMRN logo

BioMarin Pharmaceutical (BMRN) Book Value

Annual Book Value

$4.95 B
+$348.39 M+7.57%

December 31, 2023


Summary


Performance

BMRN Book Value Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBMRNbalance sheetmetrics:

Quarterly Book Value

$5.41 B
+$127.10 M+2.40%

September 30, 2024


Summary


Performance

BMRN Quarterly Book Value Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBMRNbalance sheetmetrics:

Book Value Formula

Book Value = Total Assets − Total Liabilities

BMRN Book Value Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+7.6%+9.3%
3 y3 years+20.6%+16.2%
5 y5 years+66.8%+16.2%

BMRN Book Value Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+16.1%at high+26.9%
5 y5-yearat high+58.6%at high+73.4%
alltimeall timeat high+6492.2%at high+5001.6%

BioMarin Pharmaceutical Book Value History

DateAnnualQuarterly
Sep 2024
-
$5.41 B(+2.4%)
Jun 2024
-
$5.29 B(+4.2%)
Mar 2024
-
$5.07 B(+2.5%)
Dec 2023
$4.95 B(+7.6%)
$4.95 B(+1.1%)
Sep 2023
-
$4.90 B(+2.4%)
Jun 2023
-
$4.78 B(+2.7%)
Mar 2023
-
$4.66 B(+1.2%)
Dec 2022
$4.60 B(+7.9%)
$4.60 B(+0.8%)
Sep 2022
-
$4.57 B(+1.4%)
Jun 2022
-
$4.50 B(+2.6%)
Mar 2022
-
$4.39 B(+2.9%)
Dec 2021
$4.27 B(+3.9%)
$4.27 B(-0.0%)
Sep 2021
-
$4.27 B(+0.6%)
Jun 2021
-
$4.24 B(+1.9%)
Mar 2021
-
$4.16 B(+1.4%)
Dec 2020
$4.11 B(+31.5%)
$4.11 B(+1.3%)
Sep 2020
-
$4.05 B(+25.2%)
Jun 2020
-
$3.24 B(-0.1%)
Mar 2020
-
$3.24 B(+3.8%)
Dec 2019
$3.12 B(+5.2%)
$3.12 B(+1.6%)
Sep 2019
-
$3.07 B(+3.8%)
Jun 2019
-
$2.96 B(+0.8%)
Mar 2019
-
$2.94 B(-1.1%)
Dec 2018
$2.97 B(+5.7%)
$2.97 B(+1.8%)
Sep 2018
-
$2.91 B(+1.0%)
Jun 2018
-
$2.89 B(+2.8%)
Mar 2018
-
$2.81 B(-0.1%)
Dec 2017
$2.81 B(+1.5%)
$2.81 B(-0.2%)
Sep 2017
-
$2.81 B(+0.6%)
Jun 2017
-
$2.80 B(+1.0%)
Mar 2017
-
$2.77 B(+0.1%)
Dec 2016
$2.77 B(+15.2%)
$2.77 B(+4.6%)
Sep 2016
-
$2.65 B(+38.0%)
Jun 2016
-
$1.92 B(-16.3%)
Mar 2016
-
$2.29 B(-4.6%)
Dec 2015
$2.40 B(+57.1%)
$2.40 B(+4.7%)
Sep 2015
-
$2.29 B(-2.7%)
Jun 2015
-
$2.36 B(-2.8%)
Mar 2015
-
$2.43 B(+58.7%)
Dec 2014
$1.53 B(+13.9%)
$1.53 B(+1.3%)
Sep 2014
-
$1.51 B(+3.2%)
Jun 2014
-
$1.46 B(+0.1%)
Mar 2014
-
$1.46 B(+8.9%)
Dec 2013
$1.34 B(+32.0%)
$1.34 B(+5.1%)
Sep 2013
-
$1.28 B(+1.4%)
Jun 2013
-
$1.26 B(+0.6%)
Mar 2013
-
$1.25 B(+23.1%)
Dec 2012
$1.02 B(+31.4%)
$1.02 B(+0.1%)
Sep 2012
-
$1.02 B(+1.5%)
Jun 2012
-
$1.00 B(+29.6%)
Mar 2012
-
$771.95 M(-0.1%)
Dec 2011
$773.05 M
$773.05 M(-0.2%)
DateAnnualQuarterly
Sep 2011
-
$774.54 M(+5.8%)
Jun 2011
-
$732.30 M(+1.6%)
Mar 2011
-
$720.84 M(+0.5%)
Dec 2010
$717.26 M(+122.6%)
$717.26 M(+22.5%)
Sep 2010
-
$585.66 M(+61.4%)
Jun 2010
-
$362.96 M(+5.1%)
Mar 2010
-
$345.24 M(+7.2%)
Dec 2009
$322.19 M(+16.4%)
$322.19 M(+6.0%)
Sep 2009
-
$303.85 M(+7.2%)
Jun 2009
-
$283.43 M(+3.5%)
Mar 2009
-
$273.94 M(-1.0%)
Dec 2008
$276.68 M(+47.4%)
$276.68 M(+16.3%)
Sep 2008
-
$237.90 M(+5.3%)
Jun 2008
-
$226.03 M(+8.1%)
Mar 2008
-
$209.17 M(+11.4%)
Dec 2007
$187.73 M(+59.4%)
$187.73 M(+7.6%)
Sep 2007
-
$174.54 M(+4.1%)
Jun 2007
-
$167.60 M(+1.8%)
Mar 2007
-
$164.71 M(+39.8%)
Dec 2006
$117.80 M(-252.1%)
$117.80 M(-3.5%)
Sep 2006
-
$122.12 M(+149.8%)
Jun 2006
-
$48.89 M(+6.3%)
Mar 2006
-
$46.01 M(-159.4%)
Dec 2005
-$77.46 M(+14.0%)
-$77.46 M(+18.5%)
Sep 2005
-
-$65.38 M(-40.8%)
Jun 2005
-
-$110.44 M(+22.4%)
Mar 2005
-
-$90.23 M(+32.7%)
Dec 2004
-$67.98 M(-157.7%)
-$67.98 M(-580.0%)
Sep 2004
-
$14.16 M(-67.2%)
Jun 2004
-
$43.19 M(-56.3%)
Mar 2004
-
$98.77 M(-16.2%)
Dec 2003
$117.85 M(+19.6%)
$117.85 M(-17.0%)
Sep 2003
-
$141.96 M(-12.6%)
Jun 2003
-
$162.44 M(-2.1%)
Mar 2003
-
$165.90 M(+68.4%)
Dec 2002
$98.54 M(-38.2%)
$98.54 M(-15.2%)
Sep 2002
-
$116.21 M(-11.1%)
Jun 2002
-
$130.78 M(-9.4%)
Mar 2002
-
$144.37 M(-9.5%)
Dec 2001
$159.55 M(+127.9%)
$159.55 M(+89.6%)
Sep 2001
-
$84.17 M(-9.5%)
Jun 2001
-
$93.00 M(+50.6%)
Mar 2001
-
$61.76 M(-11.8%)
Dec 2000
$69.99 M(-28.9%)
$69.99 M(-12.1%)
Sep 2000
-
$79.65 M(-4.3%)
Jun 2000
-
$83.20 M(-7.3%)
Mar 2000
-
$89.73 M(-8.8%)
Dec 1999
$98.38 M(+234.6%)
$98.38 M(-7.9%)
Sep 1999
-
$106.80 M(+513.8%)
Jun 1999
-
$17.40 M(-30.7%)
Mar 1999
-
$25.10 M
Dec 1998
$29.40 M
-

FAQ

  • What is BioMarin Pharmaceutical annual book value?
  • What is the all time high annual book value for BioMarin Pharmaceutical?
  • What is BioMarin Pharmaceutical annual book value year-on-year change?
  • What is BioMarin Pharmaceutical quarterly book value?
  • What is the all time high quarterly book value for BioMarin Pharmaceutical?
  • What is BioMarin Pharmaceutical quarterly book value year-on-year change?

What is BioMarin Pharmaceutical annual book value?

The current annual book value of BMRN is $4.95 B

What is the all time high annual book value for BioMarin Pharmaceutical?

BioMarin Pharmaceutical all-time high annual book value is $4.95 B

What is BioMarin Pharmaceutical annual book value year-on-year change?

Over the past year, BMRN annual book value has changed by +$348.39 M (+7.57%)

What is BioMarin Pharmaceutical quarterly book value?

The current quarterly book value of BMRN is $5.41 B

What is the all time high quarterly book value for BioMarin Pharmaceutical?

BioMarin Pharmaceutical all-time high quarterly book value is $5.41 B

What is BioMarin Pharmaceutical quarterly book value year-on-year change?

Over the past year, BMRN quarterly book value has changed by +$461.85 M (+9.33%)